Summary Of Trading Off Bottom - As At April 5 Close.
Summary Of Trading Off Bottom - As At April 5 Close.
April 5: .0002 - 60M / .0001 - 3M
April 4: .0002 - 43M
April 3: .0002 - 17M / .0001 - 1M [+ mirrors of 140M .0001 / .000098]
April 2: .0002 - 5M / .0001 - 10M
March 29: .0002 - 9M / .0001 - 7M [+mirrors of 220M .000098/.0001]
March 28: .0002 - 10M
March 27: .0002 - 15M / .0001 - 35M
March 26: .0002 - 10M / .0001 - 1M
March 23: .0002 - 22M / .0001 - 2M
March 22: .0002 - 17M / .0001 - 4M [+ mirrors of 280M .000098/.0001]
March 21: .0002 - 8M / .0001 insignificant paint downs of 682K discounted
March 20: .0002 - 92M / .0001 - 3M paint downs [excl 45M T that didn't go to retail bidders]
March 19: .0002 > .0003 - 92M [89M .0002 / 3M .0003]
March 16: almost all .0002 - 226M [excl 65M T that did not go to retail bidders]
March 15: .0002 > .0003 - 144M [excl 70M T that did not go to retail bidders]
March 14: .0003 > .0004 - 228M [.0002 paint discounted]
March 13: .0002 > .0004 - 833M [majority at .0003]
Prior to Move Off Of End-2017 Tax Loser Selling .0001 / .0002 Bottom:
At .0002:
December 8: 3M
December 11: 6M
December 12: 3M
December 13: 10M
December 14: 52M
December 15: 14M
December 18: 19M
December 19: 14M
December 20: 22M
December 21: 18M
December 22: 7M
December 26: 34M
December 27: 24M
December 28: 24M
December 29: 43M
January 2: 17M
January 3: 13M
January 4: 9M
January 5: 3M
January 8: 12M
January 9: 10M
January 10: 20M
January 11: 28M
January 12: 10M
January 16: 30M
January 17: 4M
January 18: 8M
January 19: 13M
January 22: 8M
January 23: 5M
January 24: 3M
January 25: 21M
January 26: 5M
January 29: 2M
January 30: 3M
January 31: 6M
February 1: 4M
February 2: 11M
February 5: 2M
February 6: 2M
February 7: 5M
February 8: 2M
February 9: 4M
February 12: 2M
February 13: 2M
February 14: 4M
February 15: 2M
February 16: 1M [rounded down]
February 20: 5M
February 21: 4M
February 22: 6M [rounded up]
February 23: 5M
February 26: 10M
February 27: 10M
February 28: 8M
March 1: 5M
March 2: 2M
March 5: 9M
March 6: 8M
March 7: 2M
March 8: 3M
March 9: 1M [rounded down]
March 12: 3 [rounded up]
Total: 645M
At .0001:
December 7: 415M [260M bought on bid / 155M bought on ask].
December 8: 366M
December 11: 8M
December 12: 219M
December 13: 22M
December 14: 25M
December 15: 1M
December 19: 3M
December 20: 19M
December 21: 6M
December 22: 3M
December 23: 2M
December 28: 10M
December 29: 5M
January 2: 2M
January 3: 12M
January 4: 9M
January 5: 2M
January 8: 20M
January 10: 7M
January 11: 5M
January 12: 2M
January 16: 8M
January 18: 2M
January 19: 15M
January 23: 1M
January 24: 2M
January 25: 3M
January 29: 1M
January 30: 1M
January 31: 9M
February 1: 6M
February 5: 2M
February 7: 1M
February 8: 1M
February 12: 5M [rounded up]
February 13: 5M [rounded down]
February 14: 3M
February 15: 1M
February 20: 10M
February 22: 4M [rounded down]
February 23: 3M [rounded up]
February 26: 4M
February 27: 20M
February 28: 3M
March 1: 3M
March 5: 3M [rounded up]
March 6: 12M [rounded down]
March 7: 3M
March 12: 8M
Total 1.073 B
In addition the following quantities of .0001s may be in the hands of retail investors if not sold even on December 7:
November 29: 4M
December 5: 170M
December 6: 113M
Total: 287M
Discounting late print of 90M + 82,540,103 at .00098 Form T on December 12 which did not got to retail.
Discounting late print of 4 x 90M + 80.699.580M at .000098 Form T on December 7 which did not go to retail.
Discounting assumed mirror trades of 4 x 90M + 20,000,200 at .000098 then at .0001 on December 5. Might need to assume later that 380M or 760M acquired at .0001 - will become evident when .0002s and .0003s bought out.
Discounting assumed mirror trades of 2 x 90M + 56,499,900 at .0001 then .000098 on November 29. Might need to assume later that 236M or 472M acquired at .0001 - will become evident when .0002s and .0003s bought out.
Tersis Technologies, Inc. (TERS) Stock Research Links
"Per Ardua Ad Astra" - "Through Adversity To The Stars"
A very apposite motto for those who trade successfully in the OTC market..
All posts are my opinion - trade at your own risk.
Scroll down for more posts ▼
Top 10 Most Recent News Articles
An Automotive Feat in R&D Now here's a story that should make waves across the automotive sector. China Automotive Systems, Inc. (NASDAQ: CAAS), a titan of power steering development in China, has nailed it by meeting the ASPICE 4.0 Capability Level 2. That's a big one, folks. Verified by a partnership between a European automaker and UL, this achievement is no fluke....
Continue Reading
Ah, the pharmaceutical game is shifting again, and this time Celltrion USA's putting their chips down with OMLYCLO, the shiny new omalizumab biosimilar. Here we see a product that's not just approved but interchangeable with XOLAIR, making it a front-runner in the allergic and inflammatory conditions battleground. If you're a patient or a provider navigating these murky...
Continue Reading
From Ashes to Airwaves Gritty stories of survival often cut deeper than any wonky industry analysis or corporate earnings report. When you've been through the wringer and come out the other side, that experience sticks with you—and for Kim S. Marshall, it ignited something personal yet universal with the #L.A. Rising podcast. Emerging from the 2025 L.A. fires, this...
Continue Reading
In the world of legal labyrinths, sometimes you just need a guiding light, especially following a car accident. That's where the freshly launched South Carolina Car Accident Law Knowledge Center steps in. It’s no magic wand, but Christmas Injury Lawyers are certainly trying to cut the chaos. This online hub covers more ground than a small library, boasting 40 guides...
Continue Reading
Getting Ahead of the Travel Expense Game Rising fees and tighter budgets haven't persuaded holiday travelers to abandon their plans. Instead, they’re sharpening their axes, looking for clearer paths to their vacation goals without slicing off an arm and a leg. With the cost of travel climbing faster than a runaway elevator, folks are getting smart about where their...
Continue Reading
Turning the Insurance World on Its Head Just when you think the enterprise software scene is getting predictable, along comes a bit of news to shake things up. Guidewire, a name known in the P&C insurance software world, has roped in a veteran—Dan Brown—who's got more than a quarter-century under his belt shaping product strategies. It’s not just another suit...
Continue Reading
An Unexpected Wave of Enthusiasm in Event Industry The Event Industry Power 50 is getting some serious action this year. Over 3,500 votes have already rolled in, smashing last year's numbers with days still left on the clock. It seems like folks can't wait to see their favorite event powerhouses crowned at this year's gala, which kicks off October 27 in New York City....
Continue Reading
Revolutionizing Cookware: The Launch of Hybrid 2.0 Today, everyone's buzzing about ProClad's big reveal—the Hybrid 2.0 Pan. Now, before you roll those skeptical eyes, hear me out. This isn’t your average bit of kitchen fluff; it’s a heavyweight contender stepping into the everyday cooking ring. What they've done here is combine the muscle of stainless steel searing...
Continue Reading
TRIMAX's Bold Move into AI-Powered Infrastructure It feels like we're standing on the cusp of a seismic shift, folks. Artificial intelligence isn't just another buzzword anymore—it's a juggernaut reshaping our digital world. TRIMAX Power Systems is gearing up to ride this wave, with its eyes set on capturing a chunk of the booming demand for fast-deployable power...
Continue Reading
A New Era for Pickleball in Palm Beach It might be time to re-evaluate pickleball if you weren't paying attention before. The Palm Beach Royals have wrapped up their first Major League Pickleball season with a bang, marking a pivotal year for the sport. This underdog tale of graft and grit is carving out a new chapter in the world of sport. Record-Breaking Season for MLP...
Continue Reading
Top 5 Most Recently Viewed Articles
Dose One: A Step Closer to an Oral Obesity Treatment August 30, 2026, marks a pivotal moment for Ascletis Pharma Inc. (HKEX: 1672, "Ascletis") as they announce the first patient dosed in their global phase III clinical trial of ASC30. This little pill might pack a punch, tackling obesity—a beast of a challenge that's battering waistlines globally. So what's the big deal...
Continue Reading
Collaboration to Enhance Lung Cancer Care Biodesix, Inc. (Nasdaq: BDSX), a prominent name in the diagnostic solutions sector, has announced an exciting new partnership with the Association of Pulmonary Advanced Practice Providers (APAPP). This collaboration aims to roll out comprehensive educational programs designed specifically for Advanced Practice Providers (APPs),...
Continue Reading
Westinghouse's Strategic Contract with GEN energija Westinghouse Electric Company announced an exciting partnership with Slovenia’s state-owned power firm GEN energija. The duo aims to conduct a comprehensive Technical Feasibility Study (TFS) focused on the deployment of the AP1000 reactor, a pivotal part of Slovenia's nuclear new-build strategy. Collaborating alongside...
Continue Reading
AbbVie Completes Acquisition of Gilgamesh Pharmaceuticals' Bretisilocin AbbVie (NYSE: ABBV) has successfully finalized its acquisition of Gilgamesh Pharmaceuticals' lead investigational compound, bretisilocin. This strategic acquisition strengthens AbbVie's commitment to pioneering innovations in psychiatric treatments. Expanding the Psychiatry Pipeline The acquisition of...
Continue Reading
Market Projections and Growth Trajectory Roll up your sleeves, folks, because the automotive wiring harness market is gearing up for some shifts. Aiming to expand from $42.95 billion in 2026 to a robust $49.29 billion by 2033, the projected CAGR clocks in at a humble 2%, but don’t be fooled—there’s more beneath the surface here that’s worth a seasoned glance. BEV...
Continue Reading